Knowledge hub

News

Ardigen Collaborates on Breakthrough in TCR Therapy Advancements

Ardigen CEO Janusz Homa Recognized Among AI Sector Leaders by Forbes Polska
Ardigen Representatives Share Expertise with Silesian University of Technology Students
Leave Your Trace Foundation and Ardigen Unveil “ONCODecalogue of Emotions” for Children Facing Health Challenges
AI Brain Slice Segmentation – Innovative Solutions for Precision Diagnostics
AI at the Forefront of Modern Radiology Analysis: Brain MRI Use Case
webinar HCS
Game-Changing Insights in HCS with Cell Painting
AI-driven method for identification of hits from phenotypic screening with Cell Painting Assay
News

Hackathon – March 2023

Ardigen and DKFZ Research Groups Collaborate to Evaluate the TCR-based Therapies (TCR-Ts)
Ardigen at SLAS International Conference & Exhibition 2023
Meet Ardigen phenAID platform
Ardigen at PMWC 2023
Mariola Fotin-Mleczek, PhD, Has Joined Ardigen’s Scientific Board
Ardigen supports JUMP-CP Consortium – The World’s Largest Public Cell Painting Dataset
Agnieszka Blum, MD, PhD, Promoted to the Ardigen Management Board
Prof. Dr. med. Michael Schmitt, MHBA in Ardigen’s Scientific Board